1/2 (Translation) Ref. HPIR 004/2018 February 28, 2018 Subject : Management Discussion and Analysis for the year ended December 31, 2017 To : The President The Stock Exchange of Thailand Duplicate

November 12, 2004 1/3 No: SN. 036/2017 May 11, 2017 Subject: Clarification of Operating Results and Financial Status the six-month period ended March 31, 2017 Attention: President The Stock Exchange

Ref. MD 115/2017 August 25, 2017 Re: Clarification on the Financial Performance of the Company and its subsidiaries as of Year 2015 Attn: President The Stock Exchange of Thailand We, K. C. Property

(Translation) No. MD119/2560 August 29, 2017 Re: Clarification on the Financial Performance of the Company and its subsidiaries as of Year 2015 Attn: President The Stock Exchange of Thailand We, K. C

ที่ - Translation - PorBor.076 / 2017 November 14, 2017 Subject: Clarification of operating results change from the same period last year by more than 20% To: President The Stock Exchange of Thailand

Exchange of Thailand Oishi Group Public Company Limited and subsidiaries clarify consolidated operating results and consolidated financial statements for 2017, ended September 30, 2017 as the followings

Baht 20.00 million, Bill of exchange Baht 105 million and UOB's loans Baht 15 million and increased from trade accounts payable by extend credit term with vendors. Shareholders' equity increased by 25.67

(Translation) Ref. No. 1808/036EN August 10, 2018 Subject: Operating Result Clarification for Q2/2018 (Ending June 30, 2018) To: Director and Manager of the Stock Exchange of Thailand Ubis (Asia

results for the nine-month period of 2019, change of rate more than 20 percent Dear Director and Manager The Stock Exchange of Thailand According to the resolution of the Board of Directors of DOD Biotech

According to referrals from the Stock Exchange of Thailand (SET) and the SEC’s further investigation, actions liable to be offenses committed by the three persons above were detected during 16